期刊文献+

4-甲基-7,10-二氢苯并[h]香豆素的合成研究 被引量:1

Study on the Synthesis of 4-Methyl-7,10-dihydrobenzo[h]coumarin
下载PDF
导出
摘要 以 1 萘酚 ( 6)为起始原料 ,经过Birch还原得到 5 ,8 二氢 1 萘酚 ( 7) ;7与乙酰乙酸乙酯在不同条件下缩合合成了 4 甲基 7,10 二氢苯并 [h]香豆素 ( 4 ) .研究结果表明 ,无氧和酸催化的反应条件对缩合反应是至关重要的 .在没有酸催化的条件下 ,反应生成 3 乙酰基 2 羟基 6 甲基 -吡喃 4 酮 ( 8) ,并通过单晶X射线衍射分析确定了产物的结构 ;在酸催化的条件下 ,除了生成产物 4外 ,还伴随生成脱氢芳构化产物 4 甲基苯并 [h]香豆素 ( 5 ) ,而且在不同条件下二者的比例不同 ,其中以甲磺酸为催化剂、在氮气保护下并加入抗氧化剂无水Na2 SO3 为最佳反应条件 ,化学选择性约为 70∶3 0 ( 4∶5 ) ,收率49 1%. 4-Methyl-7,10-dihydroxybenzo[h]coumarin (4) was prepared by condensation of ethyl acetoacetate with 5, 8-dihydro-1-naphthol (7), which was obtained by Birch reduction of 1-naphthol (6). It was found that the reaction conditions, particularly the presence of acid and the absence of oxygen, were critical for the condensation reaction. Under the acid-free condition, 3-acetyl-2-hydroxy-6-methyl-pyran-4-one (8) was obtained and its structure was confirmed by X-ray diffraction analysis. In the presence of acid, the condensation of 7 with ethyl acetoacetate proceeded to give a mixture of the expected product 4 and an aromatized derivative 4-methyl-benzo[h]coumarin (5). Under the optimized conditions (under Ar atmophere with CH3SO3H as catalyst in the presence of antioxidant Na2SO3), 4 and 5 could be obtained in 49.1% yield with chemical selectivity of 70:30 (4:5).
出处 《有机化学》 SCIE CAS CSCD 北大核心 2003年第12期1396-1399,共4页 Chinese Journal of Organic Chemistry
基金 国家自然科学基金 (No.2 0 2 72 0 1 0 )
关键词 4-甲基-7 10-二氢苯并[h]香豆素 合成 缩合反应 反应条件 抗艾滋病药物 4-methyl-7 10-dihydrobenzo[ h ] coumarin 3-acetyl-2-hydroxy-6-methyl-pyran-4-one 4-methyl-benzo[ h ]-coumarin 5,8-dihydro-1-naphthol synthesis
  • 相关文献

参考文献12

  • 1Huang, L.; Kashiwada, Y.;Cosentino, L. M.; Fan, S.;Chen, C. H.; McPhail, A. T.; Fujioka, T.; Mihashi, K.;Lee, K. H.J. Med. Chem. 1994, 37, 3947.
  • 2Romines, K. R.; Morris, J. K.; Howe, W. J.; Tomich, P.K.; Homg, M. M.; Chong, K.T.; Hinshaw, R. R.;Anderson, D. J.; Strohbach, J. W.; Turner, S. R.; Mizsak,S. A. J. Med.Chem. 1996, 39, 4125.
  • 3Woodruff, E. H. Org. Synth. 1944, 24, 69.
  • 4David Gutsche, C.; Peter Hugo H. Org. Synth. Coll. 1963,4, 887.
  • 5Arndt, F. Org. Synth. Coll. 1955, 3, 231.
  • 6Ohta, S.; Tsujimura, A.; Okamoto, M. Chem. Pharm. Bull.1981, 29, 2762.
  • 7Bertolasi, V.; Gilli, P.; Ferretti V.; Gilli, G. J. Chem.Soc., Perkin Trans. 21997, 945.
  • 8Lokot, I. P.; Pashkovsky, F. S.; Lakhvich, F. A. Tetrahedron 1999, 55, 4783.
  • 9Zheng, Y. H.; Xia, Y.; Yang, Z. Y.; Zhang, Q.; Chen,Y.; Xia, P. Chin. J. Org. Chem.2001, 21, 231 (in Chinese).(郑云红,夏奕,杨征宇,张倩,陈瑛,夏鹏,有机化学,2001,21,231.)
  • 10Liao, Y.; Hendrata, S.; Bae, S. Y.; Wang, B. Chem.Pharm. Bull. 2000, 48, 1138.

同被引文献7

  • 1Jacobsen, E. N.; Marko, I.; Mungall, W. S.; Schroder, G.; Sharpless, K. B. J. Am. Chem. Soc. 1988, 110, 1968.
  • 2Sharpless, K. B.; Amberg, W.; Bennani, Y. L.; Crispino, G. A.; Hartung, J.; Jeong, K. S.; Kwong, H. L.; Morikawa, K.; Wang, Z. M.; Xu, D.; Zhang, X. L. J.Org. Chem. 1992,57(10), 2768.
  • 3Kolb, H. C.; Van Nieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483.
  • 4Dupau, P.; Epple, R.; Thomas, A. A.; Fokin, V. V.; Sharpless, K. B. Adv. Synth. Catal. 2002, 344, 421.
  • 5Andersson, M. A.; Epple, R.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41,472.
  • 6Wang, Y.; Huang, S. X.; Xia, P.; Xia, Y.; Yang, Z. Y.; Morris-Natschke, S. L.; Lee, K. H. Bioorg. Med. Chem. Lett. 2007, 17, 4316.
  • 7Wang, Y.; Huang, S. X.; Xia, P. Synth. Commun. 2005, 35(24), 3141.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部